Join
Live feed
·
PRReleasevia Quantisnow
Polyrizon Ltd. logo

Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway

ByQuantisnow·Wall Street's wire, on your screen.
PLRZ· Polyrizon Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLRZ (Polyrizon Ltd.) and more on Quantisnow.